860 related articles for article (PubMed ID: 16841178)
41. Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.
Ma L; Hofling M; Masironi B; von Schoultz B; Cline JM; Sahlin L
Maturitas; 2008 Dec; 61(4):345-9. PubMed ID: 18980817
[TBL] [Abstract][Full Text] [Related]
42. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
[TBL] [Abstract][Full Text] [Related]
43. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
44. Progestogen use in women approaching the menopause and breast cancer risk.
Campagnoli C; Ambroggio S; Lotano MR; Peris C
Maturitas; 2009 Apr; 62(4):338-42. PubMed ID: 19118958
[TBL] [Abstract][Full Text] [Related]
45. The effects of hormone therapy, estrogen therapy and tibolone on apoptosis and cyclin D1 expression in postmenopausal vaginal epithelium.
Sağsöz N; Yücel A; Noyan V; Bozdoğan O
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):61-6. PubMed ID: 15955616
[TBL] [Abstract][Full Text] [Related]
46. [A randomized case-control study on the influence of percutaneous estradiol and progestin in cyclic combined regimen on endometrium and vaginal bleeding pattern in Chinese early postmenopausal women].
Sun A; Lin S; Wei Y
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(21):1291-4. PubMed ID: 16200718
[TBL] [Abstract][Full Text] [Related]
47. The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
Demir B; Ozturkoglu E; Solaroglu A; Baskan B; Kandemir O; Karabulut E; Haberal A
Gynecol Endocrinol; 2008 Jun; 24(6):347-53. PubMed ID: 18584415
[TBL] [Abstract][Full Text] [Related]
48. Medroxyprogesterone acetate acutely facilitates and sequentially inhibits sexual behavior in female rats.
Pazol K; Northcutt KV; Wilson ME; Wallen K
Horm Behav; 2006 Jan; 49(1):105-13. PubMed ID: 16095597
[TBL] [Abstract][Full Text] [Related]
49. Progestin treatment induces apoptosis and modulates transforming growth factor-beta in the uterine endometrium.
Rodriguez GC; Rimel BJ; Watkin W; Turbov JM; Barry C; Du H; Maxwell GL; Cline JM
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):578-84. PubMed ID: 18349275
[TBL] [Abstract][Full Text] [Related]
50. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women.
Hofling M; Hirschberg AL; Skoog L; Tani E; Hägerström T; von Schoultz B
Menopause; 2007; 14(2):183-90. PubMed ID: 17108847
[TBL] [Abstract][Full Text] [Related]
51. A novel organotypic culture model for normal human endometrium: regulation of epithelial cell proliferation by estradiol and medroxyprogesterone acetate.
Bläuer M; Heinonen PK; Martikainen PM; Tomás E; Ylikomi T
Hum Reprod; 2005 Apr; 20(4):864-71. PubMed ID: 15665014
[TBL] [Abstract][Full Text] [Related]
52. The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells.
Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
Menopause; 2005; 12(4):468-74. PubMed ID: 16037763
[TBL] [Abstract][Full Text] [Related]
53. Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice.
Panay N; Nappi RE; Stute P; Palacios S; Paszkowski T; Kagan R; Archer DF; Héroux J; Boolell M
Maturitas; 2023 Jun; 172():23-31. PubMed ID: 37084589
[TBL] [Abstract][Full Text] [Related]
54. Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.
Baselga J; Semiglazov V; van Dam P; Manikhas A; Bellet M; Mayordomo J; Campone M; Kubista E; Greil R; Bianchi G; Steinseifer J; Molloy B; Tokaji E; Gardner H; Phillips P; Stumm M; Lane HA; Dixon JM; Jonat W; Rugo HS
J Clin Oncol; 2009 Jun; 27(16):2630-7. PubMed ID: 19380449
[TBL] [Abstract][Full Text] [Related]
55. [Effects of estrogen monotherapy on breast tissue in the primate model (Macaca fascicularis)].
Foth D; Cline JM
Zentralbl Gynakol; 1997; 119(12):607-10. PubMed ID: 9483811
[TBL] [Abstract][Full Text] [Related]
56. Percutaneous estrogen in prevention of early postmenopausal bone loss in Chinese women.
Sun A; Lin S; Yu W; Qin M; Chen F; Zhang Y; Wei Y; de Lignieres B
Chin Med J (Engl); 2002 Dec; 115(12):1790-5. PubMed ID: 12622925
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.
Neubauer H; Ruan X; Schneck H; Seeger H; Cahill MA; Liang Y; Mafuvadze B; Hyder SM; Fehm T; Mueck AO
Menopause; 2013 May; 20(5):504-10. PubMed ID: 23615641
[TBL] [Abstract][Full Text] [Related]
58. The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells.
Neubauer H; Yang Y; Seeger H; Fehm T; Cahill MA; Tong X; Ruan X; Mueck AO
Menopause; 2011 Aug; 18(8):845-50. PubMed ID: 21532513
[TBL] [Abstract][Full Text] [Related]
59. [Monitoring the breast changes of Chinese postmenopausal women under long-term hormone replacement therapy by mammary ultrasonography].
Huang MT; Jiang YX; Lin SQ; Zhang Y; Zhou YZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):24-9. PubMed ID: 15052769
[TBL] [Abstract][Full Text] [Related]
60. Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer.
Alvarez-Vasquez RB; Axelrod D; Frenkel K; Newman MC; Sepkovic DW; Bradlow HL; Zumoff B
Horm Metab Res; 2003 Jun; 35(6):358-61. PubMed ID: 12920658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
